Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Andrea Messori

    Recenti Progressi in Medicina
    |December 7, 2019
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparative Efficacy of First-Line Therapeutic Options for ES-SCLC: An Indirect Comparison Using IPDfromKM-Reconstructed Individual Patient Data.

    Cancers·2026
    Same author

    Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data.

    Oncology research·2026
    Same author

    Effectiveness of patent foramen ovale occlusion devices versus medical therapy: An indirect comparison based on reconstructed individual patient data.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
    Same author

    Correction: Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials.

    Cureus·2026
    Same author

    Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III.

    Global & regional health technology assessment·2026
    Same author

    Updating Efficacy of First-Line Treatments for Chronic Lymphocytic Leukemia: Indirect Comparisons Based on Recent Data Favor the Combination of Acalabrutinib Plus Obinutuzumab.

    European journal of haematology·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    Same journal

    Recenti progressi in medicina·2026
    See all related articles